Viral Vector and Plasmid DNA Testing Services Market Size Overview | US$ 565.3 Million ROI by Top 10 Players | 2027 Business Forecast by CMI

Global Viral Vector and Plasmid DNA Testing Services Market, by Testing Services (Safety, Genetic Characterization, Purity, Identity, and Potency), By End User (Research Organizations and Pharmaceutical and Biotechnological Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 76.4 million in 2018 and is expected to exhibit a CAGR of 25.0% over the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights.

Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-sample/3637

The increasing focus of market players on developing innovative techniques in order enhance the characterization of viral vectors are expected to drive growth of the viral vector and plasmid DNA testing services market over the forecast period. For instance, Promega Corporation developed Vac-Man 96 Vacuum Manifold, which supports processing of SV 96 plates for plasmid, genomic, and PCR product purification. The product is used with Wizard SV 96 Plasmid DNA Purification System for isolation of plasmid DNA. Moreover, in September 2019, BIA Separations launched CORNERSTONE AAV Process Development Service. With this launch the company introduced CIMasphere, a purification technology that enables removal of host cell protein and host cell DNA before manufacturing, in order to deliver pure AAV products.

Major players are focused on collaborations and acquisitions, which is expected to propel the market growth over the forecast period. For instance, in November 2019, Lonza entered into a gene therapy collaboration with DiNAQOR AG. Under the collaboration, Lonza will provide preclinical, clinical, and commercialization support for DiNAQOR’s preclinical program DiNA-001, a gene therapy program. Moreover, in October 2018, Eurofins Scientific acquired EnvironeX Group Inc., a Canada-based provider of testing services in the pharmaceutical, AgriFood, and environment sectors.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/3637

North America is expected to hold a dominant position in the viral vector and plasmid DNA testing services market, owing to adoption of inorganic growth strategies such as mergers, partnerships, and acquisitions by market players, in order to expand their product portfolio and strengthen their market presence, which in turn are expected to fuel growth of the regional market over the forecast period. For instance, in February 2019, Charles River Laboratories, Inc. acquired Citoxlab, a non-clinical CRO that offers regulated safety assessment services, non-regulated discovery services, and medical device testing services for around US$ 510 million. The acquisition resulted in expansion of Charles River’s global presence as a leading contract research organization (CRO) and enhanced its offerings in the market.

Furthermore, in September 2016, Charles River Laboratories, Inc. and PathoQuest entered into a partnership, in order to offer improved viral safety service to biopharmaceutical companies.

Browse 26 Market Data Tables and 22 Figures spread through 145 pages and in-depth TOC on ‘Viral Vector and Plasmid DNA Testing Services Market’- global forecast to 2027, by Testing Services (Safety, Genetic Characterization, Purity, Identity, and Potency), by End User (Research Organizations, Pharmaceutical, and Biotechnological Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)’

To know the latest trends and insights prevalent in the Viral Vector and Plasmid DNA Testing Services Market Press Release, click the link below: https://www.coherentmarketinsights.com/press-release/viral-vector-and-plasmid-dna-testing-services-market-2932

Key Takeaways of the Viral Vector and Plasmid DNA Testing Services Market:

• The global viral vector and plasmid DNA testing services market is expected to exhibit a CAGR of 25.0% over the forecast period, owing to rising business expansion by inaugurating facility centers, merger and acquisitions, product launches, and others by market players. For instance, in May 2016, Merck KGaA announced capacity expansion of operations at its Carlsbad, California facility, in order to offer cell and gene therapy services. The facility also supports development of products from clinical to commercial scales.
• Among testing services, safety segment held a dominant position in the viral vector and plasmid DNA testing services market in 2018, owing to increasing product or service launches by the manufacturers, which is expected to propel the market growth. For instance, in September 2018, Merck KGaA launched GMP BioReliance biosafety testing laboratory in Singapore to expand its clinical testing services in the Asia Pacific market. Moreover, in January 2020, LabCorp launched a suite of cell and gene therapy development solutions from its drug development business of Covance. The solution is developed to accelerate the development of cell and gene therapy. Under this, Labcorp offers preclinical solutions and clinical solutions such as bioanalysis testing and services, and safety assessment.
• Companies operating in the global viral vector and plasmid DNA testing services market include Charles River Laboratories, Inc., WuXi AppTec Co., Ltd., Cobra Biologics and Pharmaceutical Services, Merck KGaA, Lonza, Eurofins Scientific, FinVector Vision Therapies, Advanced Bioscience Laboratories, Inc., Takara Bio Inc., ViruSure GmbH, and Genezen Laboratories.

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837